190 related articles for article (PubMed ID: 32334633)
1. PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway.
Zhang HP; Yu ZL; Wu BB; Sun FR
J Orthop Surg Res; 2020 Apr; 15(1):162. PubMed ID: 32334633
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.
Zhu LB; Jiang J; Zhu XP; Wang TF; Chen XY; Luo QF; Shu Y; Liu ZL; Huang SH
Int J Clin Exp Pathol; 2014; 7(7):3984-91. PubMed ID: 25120775
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.
Zhao X; Fang Y; Wang X; Yang Z; Li D; Tian M; Kang P
Int J Oncol; 2020 Jan; 56(1):206-218. PubMed ID: 31746363
[TBL] [Abstract][Full Text] [Related]
4. COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling.
Zhang X; Qu P; Zhao H; Zhao T; Cao N
Mol Med Rep; 2019 Oct; 20(4):3811-3819. PubMed ID: 31485669
[TBL] [Abstract][Full Text] [Related]
5. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
7. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
[TBL] [Abstract][Full Text] [Related]
8. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
[TBL] [Abstract][Full Text] [Related]
9. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
Tan S; Chao R
Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
[TBL] [Abstract][Full Text] [Related]
10. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
11. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Li YJ; Dong BK; Fan M; Jiang WX
Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
[TBL] [Abstract][Full Text] [Related]
12. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
Qu Q; He Z; Jiang Y; Lu D; Long X; Ding Y; Xu B; He X
Med Sci Monit; 2019 Oct; 25():7527-7537. PubMed ID: 31589596
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma.
Liu Y; Cheng Z; Pan F; Yan W
Oncol Res; 2017 Jul; 25(6):989-999. PubMed ID: 28244849
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.
Wang S; Zhao G; Zhao S; Qiao Y; Yang H
Med Sci Monit; 2020 Apr; 26():e920766. PubMed ID: 32312946
[TBL] [Abstract][Full Text] [Related]
15. Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
Huang Y; Chen J; Yang S; Tan T; Wang N; Wang Y; Zhang L; Yang C; Huang H; Luo J; Luo X
Drug Des Devel Ther; 2020; 14():4625-4637. PubMed ID: 33154629
[TBL] [Abstract][Full Text] [Related]
16. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.
Wei Z; Xia K; Zheng D; Gong C; Guo W
Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274
[TBL] [Abstract][Full Text] [Related]
17. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
Huang S; Jin A
J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
[TBL] [Abstract][Full Text] [Related]
18. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
[TBL] [Abstract][Full Text] [Related]
19. [microRNA-16-5p targeted tetraspanin 15 gene to inhibit the proliferation, migration and invasion of osteosarcoma cell through phospoinositide 3-kinase/protein kinase B signaling pathway].
Yu JB; Zhang HJ; Yan LW; Chang F; Jia ZW; Yang XR
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(21):1668-1675. PubMed ID: 32486604
[No Abstract] [Full Text] [Related]
20. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]